ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

As the largest provider of statistical software and advanced analytics for clinical trial design and execution we support partners in their clinical development programs. Cytel’s deep scientific expertise and unparalleled technology can help accelerate your drug development programs to reach patients even faster, advancing the future of human health. 

Fill out the form to book a meeting with a Cytel team member. 

Don't miss Cytel presentations at the ASA Workshop: 

• Date and Time: 29th September, 2:50 PM
• Chair & Organizer: Yannis Jemiai, Chief Scientific Officer, Cytel

• • Date and Time: 29th September, 8:30 AM
    
  • Presenter: Kyle Wathen, VP Scientific Strategy and Innovation, Cytel

Parallel Session (PS4C): Decision-making using the Bayesian paradigm: industry and regulatory perspectives & Presentation: Bayesian Phase 3 Case Study: BNT162b2 mRNA COVID-19 
Vaccine Development

• Date and Time: 29th September, 8:30 AM
  
• Session Organizer and Presentation Panelist: Natalia Muehlemann, VP Strategic Consulting, Cytel

• • Date and Time: 29th September, 10:45 AM
    
  • Organizer and Chair: Natalia Muehlemann, VP Strategic Consulting
    

• • Date and Time: 27th September, 8:30 AM
    
  • Instructor: Yuan Ji, Research and Innovation Consultant, Cytel

• • Date and Time: 28th September, 5:45 PM
    
  • Authors: Emily Woolley, Senior Director PBS & Kent Koprowicz, Vice President DMC, Cytel

Roundtable Discussion (FL07): Data-Monitoring Committees: Best Practices for Now and the Future

• • Date and Time: 29th September, 12:00 PM
    
  • Presenting Leader: David Kerr, Director DMC, Cytel